Jeil Pharm Capital Reinvestment Ratio
Jeil Pharm capital reinvestment ratio. Jeil Pharm (002620) has a Capital Reinvestment Ratio of 3.85x as of March 2026, meaning it reinvests 4% of its operating cash flow (₩447.08 Million) in capital expenditures (₩1.72 Billion). Check cash flow reinvestment rate of Jeil Pharm to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jeil Pharm (2011–2025)
Capital reinvestment ratio of Jeil Pharm from 2011 to 2025. This chart tracks Jeil Pharm's Capital Reinvestment Ratio across 8 annual periods. Also explore Jeil Pharm net asset momentum to track the company's year-over-year net asset growth rate.
Jeil Pharm Capital Reinvestment Ratio by Year (2011–2025)
Jeil Pharm capital reinvestment ratio by year from 2011 to 2025. For the full cash flow conversion analysis, see 002620 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 23.90x | ₩390.26 Million | ₩9.33 Billion | ▲ +1481.9% |
| 2024 | 1.51x | ₩4.54 Billion | ₩6.86 Billion | ▼ -14.5% |
| 2021 | 1.77x | ₩13.40 Billion | ₩23.69 Billion | ▲ +18.3% |
| 2019 | 1.49x | ₩25.22 Billion | ₩37.69 Billion | ▲ +201.2% |
| 2017 | 0.50x | ₩5.92 Billion | ₩2.94 Billion | ▼ -81.4% |
| 2016 | 2.67x | ₩11.36 Billion | ₩30.33 Billion | ▲ +8.7% |
| 2015 | 2.46x | ₩2.74 Billion | ₩6.74 Billion | ▲ +159.2% |
| 2011 | 0.95x | ₩23.63 Billion | ₩22.40 Billion | — |